» Authors » Stephan Zeiter

Stephan Zeiter

Explore the profile of Stephan Zeiter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 92
Citations 642
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gantenbein F, Hartnack S, Zeiter S, Calvet C, Seebeck P
Lab Anim . 2025 Mar; :236772241297784. PMID: 40079645
Surgery is an integral part of many experimental studies. Good surgical practice is a prerequisite for surgical success, optimal animal welfare, and it not only improves post-operative recovery but also...
2.
Siverino C, Gens L, Buchholz T, Constant C, Ernst M, Gehweiler D, et al.
NPJ Biofilms Microbiomes . 2025 Feb; 11(1):35. PMID: 39994236
The management of fracture-related infection (FRI) with Debridement, Antibiotics, Irrigation, and Implant Retention (DAIR) is an appealing option, but its suitability is restricted to a relatively narrow proportion of patients....
3.
Chen B, Ponce Benavente L, Chitto M, Post V, Constant C, Zeiter S, et al.
NPJ Biofilms Microbiomes . 2024 Aug; 10(1):77. PMID: 39209878
Fracture-related infections (FRIs), particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA), are challenging to treat. This study designed and evaluated a hydrogel loaded with a cocktail of bacteriophages and vancomycin...
4.
Sheehy E, von Diemling C, Ryan E, Widaa A, O Donnell P, Ryan A, et al.
Biomaterials . 2024 Aug; 313:122774. PMID: 39208699
Osteomyelitis (OM) is a progressive, inflammatory infection of bone caused predominately by Staphylococcus aureus. Herein, we engineered an antibiotic-eluting collagen-hydroxyapatite scaffold capable of eliminating infection and facilitating bone healing. An...
5.
Mdingi V, Gens L, Mys K, Varga P, Zeiter S, Marais L, et al.
Antibiotics (Basel) . 2024 Aug; 13(8). PMID: 39200015
Non-steroidal anti-inflammatory drugs (NSAIDs) are crucial components of multimodal analgesia for musculoskeletal injuries, targeting cyclooxygenase (COX) enzymes (COX-1 and/or COX-2 isoenzymes). Concerns exist regarding their potential interference with bone healing...
6.
Puetzler J, Vallejo Diaz A, Gosheger G, Schulze M, Arens D, Zeiter S, et al.
Bone Joint Res . 2024 Mar; 13(3):127-135. PMID: 38517016
Aims: Fracture-related infection (FRI) is commonly classified based on the time of onset of symptoms. Early infections (< two weeks) are treated with debridement, antibiotics, and implant retention (DAIR). For...
7.
Hofstee M, Siverino C, Saito M, Meghwani H, Tapia-Dean J, Arveladze S, et al.
JBMR Plus . 2024 Mar; 8(2):ziad005. PMID: 38505530
is the most common pathogen that causes implant-associated osteomyelitis, a clinically incurable disease. Immune evasion of relies on various mechanisms to survive within the bone niche, including the secretion of...
8.
Siverino C, Tirkkonen-Rajasalo L, Freitag L, Gunther C, Thompson K, Styger U, et al.
Bone . 2024 Jan; 180:117011. PMID: 38176642
Osteoporosis poses a major public health challenge, and it is characterized by low bone mass, deterioration of the microarchitecture of bone tissue, causing a consequent increase in bone fragility and...
9.
Panebianco C, Constant C, Vernengo A, Nehrbass D, Gehweiler D, DiStefano T, et al.
JOR Spine . 2023 Dec; 6(4):e1293. PMID: 38156055
Background: Intervertebral disc (IVD) disorders (e.g., herniation) directly contribute to back pain, which is a leading cause of global disability. Next-generation treatments for IVD herniation need advanced preclinical testing to...
10.
Siverino C, Vanvelk N, Nehrbass D, Mischler D, Richards R, Morgenstern M, et al.
BMC Musculoskelet Disord . 2023 Nov; 24(1):886. PMID: 37964215
Background: Long bone defects resulting from primary trauma or secondary to debridement of fracture-related infection (FRI) remain a major clinical challenge. One approach often used is the induced membrane technique...